New Herbal Formula Promotes Weight Loss by Controlling Appetite, Reveals Nature Queen’s Research Study
Preliminary findings indicate a formula containing Lobelia Inflata may help to reduce weight by controlling appetite. A clinical trial to support this finding will be conducted by the Universidad de las Americas in Quito, Ecuador.
Miami, FL (PRWEB) October 08, 2013
Nature Queen, a family-owned company based in Miami, Florida, and which is a researcher and developer of herbal products to lose weight, announced today preliminary findings in a new research study indicating a formula containing Lobelia Inflata, combined with other herbal extracts, may help to reduce weight by controlling appetite. Lobelia Inflata is an annual or biennial herbaceous plant historically used by Native Americans to treat respiratory and muscle disorders and also is being used in smoking cessation products.
"Our company’s focus always has centered on appetite control because it consistently reduces and keeps weight off more than any other method. No matter which diet program or weight loss systems you’re using, you have to control your appetite or you may not have long-term success," said Cid Abreu, President of Nature Queen.
Abreu said further, "As a result of our continued research and our steadfast commitment to offer the best weight loss product, we have developed this new product containing Lobelia Inflata which, when combined with other herbal extracts, has shown to be highly effective in suppressing appetite.”
Nature Queen is confident that this new formula is the solution they had been searching for a long time to fight obesity and excess weight by curving an individual’s appetite and food cravings. Nevertheless, Abreu added, “We don’t want to bring this product to the market until we implement clinical trials to further explore and prove the effectiveness of Lobelia Inflata in this new formula.”
Abreu concluded, "We are pleased to announce that a double blind clinical study for this new weight loss formula will be conducted by the Universidad de las Americas in Quito, Ecuador to further support our preliminary findings. Results of the clinical study will be released upon completion."
For more information about this finding, Cid Abreu can be contacted at: cid(at)naturequeen(dot)us.
For the original version on PRWeb visit: http://www.prweb.com/releases/2013/10/prweb11191634.htm